Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (334) 334
Publication (21) 21
Book / eBook (7) 7
Conference Proceeding (3) 3
Magazine Article (3) 3
Book Chapter (2) 2
Dissertation (2) 2
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (191) 191
female (133) 133
middle aged (100) 100
adult (99) 99
oncology (92) 92
male (82) 82
aged (76) 76
index medicus (56) 56
antineoplastic combined chemotherapy protocols - therapeutic use (43) 43
treatment outcome (39) 39
cancer (32) 32
chemotherapy (29) 29
ovarian neoplasms - drug therapy (29) 29
survival (29) 29
antineoplastic agents - therapeutic use (27) 27
prognosis (26) 26
animals (25) 25
ovarian cancer (25) 25
aged, 80 and over (24) 24
melanoma (24) 24
carcinoma (23) 23
drug administration schedule (22) 22
ovarian neoplasms - pathology (20) 20
survival rate (20) 20
survival analysis (19) 19
melanoma - drug therapy (18) 18
analysis (17) 17
carcinoma, renal cell - drug therapy (17) 17
cisplatin (17) 17
kidney neoplasms - drug therapy (17) 17
adolescent (16) 16
antineoplastic combined chemotherapy protocols - adverse effects (16) 16
follow-up studies (16) 16
risk factors (16) 16
therapy (16) 16
trial (16) 16
combined modality therapy (15) 15
kidney neoplasms - pathology (15) 15
renal cell carcinoma (15) 15
antineoplastic agents - adverse effects (14) 14
article (14) 14
carboplatin (14) 14
dermatology (14) 14
doxorubicin - administration & dosage (14) 14
research (14) 14
disease-free survival (13) 13
hematology, oncology and palliative medicine (13) 13
interleukin-2 - administration & dosage (13) 13
melanoma - therapy (13) 13
neoplasm staging (13) 13
phase-ii (13) 13
time factors (13) 13
carcinoma, renal cell - pathology (12) 12
cisplatin - administration & dosage (12) 12
doxorubicin (12) 12
interleukin-2 (12) 12
medicine, general & internal (12) 12
melanoma - secondary (12) 12
retrospective studies (12) 12
dose-response relationship, drug (11) 11
interleukin-2 - therapeutic use (11) 11
neoplasm metastasis (11) 11
care and treatment (10) 10
gynecologic-oncology-group (10) 10
interleukin-2 - adverse effects (10) 10
ovarian neoplasms - mortality (10) 10
paclitaxel (10) 10
skin neoplasms - pathology (10) 10
antineoplastic agents - administration & dosage (9) 9
bone marrow transplantation (9) 9
carboplatin - administration & dosage (9) 9
carcinoma - drug therapy (9) 9
cyclophosphamide (9) 9
hematology (9) 9
infusions, intravenous (9) 9
interferon-alpha (9) 9
malignant-melanoma (9) 9
melphalan - therapeutic use (9) 9
mice (9) 9
multiple myeloma - drug therapy (9) 9
obstetrics & gynecology (9) 9
plant sciences (9) 9
prognostic factors (9) 9
remission induction (9) 9
agronomy (8) 8
immunotherapy (8) 8
melphalan - administration & dosage (8) 8
neoplasm recurrence, local (8) 8
ovarian neoplasms - surgery (8) 8
paclitaxel - administration & dosage (8) 8
prospective studies (8) 8
recurrence (8) 8
skin neoplasms - drug therapy (8) 8
skin neoplasms - therapy (8) 8
carcinoma, renal cell (7) 7
cisplatin - therapeutic use (7) 7
clinical study (7) 7
combination (7) 7
dacarbazine (7) 7
drug evaluation (7) 7
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Gene therapy can cause leukaemia: No shock, mild horror but a probe
by Gore, M.E
Gene Therapy, ISSN 0969-7128, 01/2003, Volume 10, Issue 1, p. 4
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24
by Goode, E.L and Chenevix-Trench, G and Song, H and Ramus, S.J and Notaridou, M and Lawrenson, K and Widschwendter, M and Vierkant, R.A and Larson, M.C and Kjaer, S.K and Birrer, M.J and Berchuck, A and Schildkraut, J and Tomlinson, I.P and Kiemeney, L.A.L.M and Cook, L.S and Gronwald, J and Garcia-Closas, M and Gore, M.E and Campbell, I and Whittemore, A.S and Sutphen, R and Phelan, C.M and Anton-Culver, H and Pearce, C.L and Lambrechts, D and Rossing, M.A and Chang-Claude, J and Moysich, K.B and Goodman, M.T and Dork, T and Nevanlinna, H and Ness, R.B and Rafnar, T and Hogdall, E and Fridley, B.L and Cunningham, J.M and Sieh, W and McGuire, V and Godwin, A.K and Cramer, D.W and Hernandez, D and Levine, D and Lu, K and Iversen, E.S and Palmieri, R.T and Houlston, R.S and Altena, A.M. van and Aben, K.K.H and Massuger, L.F.A.G and Brooks-Wilson, A and Kelemen, L.E and Le, N.D and Jakubowska, A and Lubinski, J and Meek, K and Stafford, A and Easton, D.F and Tyrer, J.P and Bolton, K.L and Harrington, P and Eccles, D and Chen, A and Molina, A.N and Davila, B.N and Arango, H and Tsai, Y.Y and Chen, Z and Risch, H.A and McLaughlin, J and Narod, S and Ziogas, A and Brewster, W and Gentry-Maharaj, A and Menon, U and Wu, A.H and Stram, D.O and Pike, M.C and Beesley, J and Webb, P.M and Chen, X and Ekici, A.B and Thiel, F.C and Beckmann, M.W and Yang, H and Wentzensen, N and Lissowska, J and Fasching, P.A and Despierre, E and Amant, F and Vergote, I and Doherty, J and Hein, R and Wang-Gohrke, S and Lurie, G and Carney, M.E and Thompson, P and OCAC and Wellcome Trust Case-Control Conso and Australian Ovarian Canc Study Grp and Australian Canc Study Ovarian Canc and Australian Ovarian Cancer Study Group and Wellcome Trust Case-Control Consortium and Australian Cancer Study (Ovarian Cancer) and Ovarian Cancer Association Consortium (OCAC) and the Ovarian Cancer Association Consortium (OCAC) and The Wellcome Trust Case-Control Consortium and The Australian Ovarian Cancer Study Group and The Australian Cancer Study (Ovarian Cancer)
Nature Genetics, ISSN 1061-4036, 2010, Volume 42, Issue 10, pp. 874 - 879
Ovarian cancer accounts for more deaths than all other gynecological cancers combined. To identify common low-penetrance ovarian cancer susceptibility genes,... 
POLY(ADP-RIBOSE) POLYMERASE | CELLS | MULTIPLE LOCI | GENE | VARIANTS | GENETICS & HEREDITY | Chromosomes, Human, Pair 8 - genetics | Genetic Predisposition to Disease | Genome-Wide Association Study | Ovary - pathology | Humans | Proto-Oncogene Proteins c-myb - genetics | Genotype | Phosphoproteins - genetics | DNA-Binding Proteins - genetics | Case-Control Studies | Homeodomain Proteins - genetics | Ovarian Neoplasms - genetics | Chromosomes, Human, Pair 2 - genetics | Polymorphism, Single Nucleotide - genetics | Female | Biomarkers, Tumor - genetics | Genome, Human | Clinical Trials, Phase I as Topic | Clinical Trials, Phase II as Topic | Ovary - metabolism | Prevention | Evaluation | Genetic susceptibility | Genomics | Oncology, Experimental | Genetic aspects | Genomes | Research | Risk factors | Cancer | Ovarian cancer | Studies | Medical research | Hospitals | Biomedical research | Councils | Health services | Family medical history | Public health
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Common variants at 19p13 are associated with susceptibility to ovarian cancer
by Bolton, K.L and Tyrer, J.P and Song, H and Ramus, S.J and Notaridou, M and Jones, C and Sher, T and Gentry-Maharaj, A and Wozniak, E and Tsai, Y.Y and Weidhaas, J and Paik, D and Berg, D. Van den and Stram, D.O and Pearce, C.L and Wu, A.H and Brewster, W and Anton-Culver, H and Ziogas, A and Narod, S and Levine, D.A and Kaye, S.B and Brown, R and Paul, J and Flanagan, J and Sieh, W and McGuire, V and Whittemore, A.S and Campbell, I and Gore, M.E and Lissowska, J and Yang, H.P and Meek, K and Gronwald, J and Lubinski, J and Jakubowska, A and Le, N.D and Cook, L.S and Keleman, L.E and Brook-Wilson, A and Massuger, L.F.A.G and Kiemeney, L.A.L.M and Aben, K.K.H and Altena, A.M. van and Houlston, R.S and Tomlinson, I and Palmieri, R.T and Moorman, P.G and Schildkraut, J and Iversen, E.S and Phelan, C.M and Vierkant, R.A and Cunningham, J.M and Goode, E.L and Fridley, B.L and Kruger-Kjaer, S and Blaeker, J and Hogdall, E and Hogdall, C and Gross, J and Karlan, B.Y and Ness, R.B and Edwards, R.P and Odunsi, K and Moyisch, K.B and Baker, J.A and Modugno, F and Heikkinenen, T and Butzow, R and Nevanlinna, H and Leminen, A and Bogdanova, N and Antonenkova, N and Doerk, T and Hillemanns, P and Durst, M and Runnebaum, I and Thompson, P.J and Carney, M.E and Goodman, M.T and Lurie, G and Wang-Gohrke, S and Hein, R and Chang-Claude, J and Rossing, M.A and Cushing-Haugen, K.L and Doherty, J and Chen, C and Rafnar, T and Besenbacher, S and Sulem, P and Stefansson, K and Birrer, M.J and Australian Ovarian Canc Study Grp and Ovarian Canc Assoc Consortium and Australian Canc Study Ovarian Canc and Australian Ovarian Cancer Study Group and Ovarian Cancer Association Consortium and Australian Cancer Study (Ovarian Cancer) and on behalf of the Ovarian Cancer Association Consortium and the Australian Ovarian Cancer Study Group and the Australian Cancer Study (Ovarian Cancer)
Nature Genetics, ISSN 1061-4036, 2010, Volume 42, Issue 10, pp. 880 - 884
Epithelial ovarian cancer (EOC) is the leading cause of death from gynecological malignancy in the developed world, accounting for 4% of the deaths from cancer... 
COMPLEX | BRCA1 | GENETICS & HEREDITY | GENOME-WIDE ASSOCIATION | Oligonucleotide Array Sequence Analysis | Adenocarcinoma, Mucinous - pathology | Humans | Middle Aged | Ovarian Neoplasms - pathology | Gene Expression Profiling | Cystadenocarcinoma, Serous - genetics | Cystadenocarcinoma, Serous - pathology | Case-Control Studies | Ovarian Neoplasms - genetics | Chromosomes, Human, Pair 19 - genetics | Endometrial Neoplasms - genetics | Female | Tumor Cells, Cultured | Ovary - metabolism | Genetic Predisposition to Disease | Genome-Wide Association Study | Ovary - pathology | Genotype | Adaptor Proteins, Signal Transducing - genetics | Polymorphism, Single Nucleotide - genetics | Endometrial Neoplasms - pathology | Adenocarcinoma, Clear Cell - pathology | Biomarkers, Tumor - genetics | Adenocarcinoma, Mucinous - genetics | Genome, Human | Adenocarcinoma, Clear Cell - genetics | Prevention | Evaluation | Genetic susceptibility | Genetic variation | Identification and classification | Risk factors | Ovarian cancer | Studies | Medical research | Hospitals | Biomedical research | Councils | Health services | Histology | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Cutaneous adverse events associated with vemurafenib in patients with metastatic melanoma: practical advice on diagnosis, prevention and management of the main treatment‐related skin toxicities
by Sinha, R and Edmonds, K and Newton‐Bishop, J.A and Gore, M.E and Larkin, J and Fearfield, L
British Journal of Dermatology, ISSN 0007-0963, 11/2012, Volume 167, Issue 5, pp. 987 - 994
Summary Until recently, no effective treatment was available for patients with metastatic malignant melanoma, and median overall survival was little more than... 
PATHWAY | RAS MUTATIONS | PHASE-III | KIT | BRAF INHIBITORS | IMPROVED SURVIVAL | DACARBAZINE | SORAFENIB | IPILIMUMAB | LESIONS | DERMATOLOGY | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Drug Eruptions - etiology | Indoles - adverse effects | Skin Neoplasms - drug therapy | Drug Eruptions - diagnosis | Humans | Melanoma - drug therapy | Sulfonamides - adverse effects | Clinical Trials as Topic | Drug Eruptions - prevention & control | Protein Kinase Inhibitors - adverse effects | Prevention | Complications and side effects | Care and treatment | Algorithms | Gene mutations | Melanoma | Skin | Metastasis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text (911) - Measuring EBV in Lung Transplant Patients - Lessons of 16 Years of Follow Up
by Gore, E.J and van der Bij, W and Leer, C.C and Erasmus, M.E and Gan, C and Verschuuren, E.A
Journal of Heart and Lung Transplantation, ISSN 1053-2498, 04/2018, Volume 37, Issue 4, pp. S356 - S357
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Revised U.K. guidelines for the management of cutaneous melanoma 2010: Bad Guidelines
by Marsden, J.R and Newton-Bishop, J.A and Burrows, L and Cook, M and Corrie, P.G and Cox, N.H and Gore, M.E and Lorigan, P and MacKie, R and Nathan, P and Peach, H and Powell, B and Walker, C
British Journal of Dermatology, ISSN 0007-0963, 08/2010, Volume 163, Issue 2, pp. 238 - 256
treatment | investigation | melanoma | evidence | guideline
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Scalar predictors of premixed gas ignition by a suddenly-starting hot jet
by Feyz, M.E and Hasti, V.R and Gore, J.P and Chowdhury, A and Nalim, M.R
International Journal of Hydrogen Energy, ISSN 0360-3199, 09/2019, Volume 44, Issue 42, pp. 23793 - 23806
Hot-jet ignition is usually designed to reduce emissions in lean-burn combustion engines, and has potential in enabling novel pressure-gain combustion.... 
Transient jet | Large eddy simulation | Hot jet ignition | ELECTROCHEMISTRY | COMBUSTION | DISSIPATION RATE | ENERGY & FUELS | ENGINE | CHEMISTRY, PHYSICAL | TURBULENT | METHANE/AIR MIXTURES | FLAME | ENTRAINMENT | LARGE-EDDY SIMULATION | INJECTION | AUTO-IGNITION
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Revised U.K. guidelines for the management of cutaneous melanoma 2010
by Marsden, J.R and Newton-Bishop, J.A and Burrows, L and Cook, M and Corrie, P.G and Cox, N.H and Gore, M.E and Lorigan, P and MacKie, R and Nathan, P and Peach, H and Powell, B and Walker, C and British Association of Dermatologists Clinical Standards Unit
British Journal of Dermatology, ISSN 0007-0963, 08/2010, Volume 163, Issue 2, pp. 238 - 256
treatment | investigation | melanoma | evidence | guideline | SURGICAL-MANAGEMENT | MALIGNANT-MELANOMA | SENTINEL-NODE | ISOLATED LIMB PERFUSION | LENTIGO MALIGNA | DERMATOLOGY | LYMPH-NODE METASTASES | POSITRON-EMISSION-TOMOGRAPHY | RANDOMIZED PHASE-III | EXCISION MARGINS | NEEDLE-ASPIRATION-CYTOLOGY | Skin Neoplasms - pathology | Melanoma - diagnosis | Lymph Nodes - pathology | Skin Neoplasms - therapy | Humans | Male | United Kingdom | Antineoplastic Agents - therapeutic use | Interferons - therapeutic use | Melanoma - secondary | Pregnancy | Skin Neoplasms - diagnosis | Female | Referral and Consultation | Sentinel Lymph Node Biopsy | Chemotherapy, Adjuvant | Melanoma - therapy | Melanoma
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text MR Simulation for Esophageal Cancer: Imaging Protocol and Gross Tumor Volume Comparison Between MRI, CT, and PET/CT
by Botros, M.E and Gore, E.M and Johnstone, C and Knechtges, P.M and Paulson, E.S
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2015, Volume 93, Issue 3, pp. S191 - S191
Radiology | Hematology, Oncology and Palliative Medicine | Tomography | Esophageal cancer | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Prognostic factors for survival in 1059 patients treated with sunitinib for metastatic renal cell carcinoma
by Motzer, R.J and Escudier, B and Bukowski, R and Rini, B.I and Hutson, T.E and Barrios, C.H and Lin, X and Fly, K and Matczak, E and Gore, M.E
British Journal of Cancer, ISSN 0007-0920, 06/2013, Volume 108, Issue 12, pp. 2470 - 2477
Background: Prognostic factors for progression-free survival (PFS), overall survival (OS), and long-term OS (>= 30 months) were investigated in... 
sunitinib | metastatic | EFFICACY | survival | prognostic factors | CYTOKINE | renal cell carcinoma | PHASE-II TRIAL | INTERFERON-ALPHA | ONCOLOGY | JAPANESE PATIENTS | 1ST-LINE THERAPY | PROGRESSION | Multivariate Analysis | Prognosis | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Young Adult | Neoplasm Metastasis | Antineoplastic Agents - adverse effects | Aged, 80 and over | Pyrroles - adverse effects | Adult | Female | Retrospective Studies | Carcinoma, Renal Cell - drug therapy | Pyrroles - therapeutic use | Carcinoma, Renal Cell - pathology | Survival Rate | Kidney Neoplasms - mortality | Carcinoma, Renal Cell - mortality | Indoles - adverse effects | Survival Analysis | Indoles - therapeutic use | Kidney Neoplasms - pathology | Aged | Kidney Neoplasms - drug therapy | Clinical Study
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma
by Gore, M.E and Szczylik, C and Porta, C and Bracarda, S and Bjarnason, G.A and Oudard, S and Lee, S.-H and Haanen, J and Castellano, D and Vrdoljak, E and Schöffski, P and Mainwaring, P and Hawkins, R.E and Crinò, L and Kim, T.M and Carteni, G and Eberhardt, W.E.E and Zhang, K and Fly, K and Matczak, E and Lechuga, M.J and Hariharan, S and Bukowski, R
British Journal of Cancer, ISSN 0007-0920, 06/2015, Volume 113, Issue 1, pp. 12 - 19
Background: We report final results with extended follow-up from a global, expanded-access trial that pre-regulatory approval provided sunitinib to metastatic... 
sunitinib | tyrosine kinase inhibitor | Renal cell carcinoma | prognosis | expanded-access trial | SURVIVAL | CYTOREDUCTIVE NEPHRECTOMY | EFFICACY | SAFETY | SORAFENIB | FACTOR RECEPTOR | SU11248 | renal cell carcinoma | INTERFERON-ALPHA | ONCOLOGY | ENDOTHELIAL GROWTH-FACTOR | Carcinoma, Renal Cell - pathology | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Young Adult | Neoplasm Metastasis | Indoles - adverse effects | Antineoplastic Agents - adverse effects | Aged, 80 and over | Pyrroles - adverse effects | Adult | Female | Indoles - therapeutic use | Kidney Neoplasms - pathology | Aged | Carcinoma, Renal Cell - drug therapy | Kidney Neoplasms - drug therapy | Pyrroles - therapeutic use | Clinical Studies
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Challenges and opportunities for converting renal cell carcinoma into a chronic disease with targeted therapies
by Gore, M.E and Larkin, J.M.G
British Journal of Cancer, ISSN 0007-0920, 02/2011, Volume 104, Issue 3, pp. 399 - 406
Optimum efficacy is the primary goal for any cancer therapy, and entails controlling tumour growth and prolonging survival as far as possible. The prognosis... 
sequential therapy | targeted agents | combinatorial therapy | renal cell carcinoma | sunitinib malate | chronic disease | 1ST-LINE TREATMENT | EVEROLIMUS | BEVACIZUMAB | SORAFENIB | CANCER | PHASE-II TRIAL | INTERFERON-ALPHA | ONCOLOGY | TEMSIROLIMUS | DOUBLE-BLIND | SUNITINIB | Carcinoma, Renal Cell - mortality | Prognosis | Carcinoma, Renal Cell - secondary | Humans | Survival Analysis | Kidney Neoplasms - pathology | Antineoplastic Agents - therapeutic use | Carcinoma, Renal Cell - drug therapy | Kidney Neoplasms - drug therapy | Kidney Neoplasms - mortality | Chronic Disease | Reviews | Clinical trials | Drug development | Drug resistance | Metastases | Minireview
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Erratum: The role of human endogenous retrovirues in melanoma (British Journal of Dermatology (2009) 161 (1225-1231))
by Singh S, S and Kaye S, S and Gore M.E, M.E
British Journal of Dermatology, ISSN 0007-0963, 12/2009, Volume 161, Issue 6, p. 1424
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Large eddy simulation of hot jet ignition in moderate and high-reactivity mixtures
by Feyz, M.E and Hasti, V.R and Gore, J.P and Nalim, M.R
Computers and Fluids, ISSN 0045-7930, 04/2019, Volume 183, pp. 28 - 37
Hot jet ignition technology is a promising improvement to conventional spark ignition for reducing emissions in premixed combustion engines as it can extend... 
Auto-ignition | LES | Hot jet ignition | COMBUSTION | MECHANISM | VALIDATION | SCALAR DISSIPATION RATE | FLAME | COMPUTER SCIENCE, INTERDISCIPLINARY APPLICATIONS | MECHANICS | METHANE | TEMPERATURE | DYNAMICS | Combustion | Air quality management | Hydrogen | Analysis | Formaldehyde | Reactive environments | Spark ignition | Turbulent flow | Computer simulation |